AFT Pharmaceuticals Ltd banner
A

AFT Pharmaceuticals Ltd
ASX:AFP

Watchlist Manager
AFT Pharmaceuticals Ltd
ASX:AFP
Watchlist
Price: 3.07 AUD Market Closed
Market Cap: AU$321.9m

Wall St Price Targets

AFP Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFP is 3.94 AUD with a low forecast of 3.57 AUD and a high forecast of 4.41 AUD.

Lowest Forecast
Price Target
3.57 AUD
16% Upside
Average Forecast
Price Target
3.94 AUD
28% Upside
Highest Forecast
Price Target
4.41 AUD
44% Upside
AFT Pharmaceuticals Ltd Competitors:
Price Targets
MAT
Mattel Inc
39% Upside

Revenue
Forecast

15% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 18%.

Gross Profit
Forecast

15% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%.

Operating Income
Forecast

26% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
26% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 12 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 3 years is 29%.

Pre-Tax Income
Forecast

39% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
12%
Average Beat
39% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
12%
Average Beat

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 32%.

Net Income
Forecast

43% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat
43% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat

Over the last 12 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 3 years is 30%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AFP's stock price target?
Price Target
3.94 AUD

According to Wall Street analysts, the average 1-year price target for AFP is 3.94 AUD with a low forecast of 3.57 AUD and a high forecast of 4.41 AUD.

What is the Revenue forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
18%

Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 18%.

What is the Operating Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
29%

Over the last 12 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 3 years is 29%.

What is the Pre-Tax Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
32%

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 32%.

What is the Net Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
30%

Over the last 12 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 3 years is 30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett